0000885590-13-000080.txt : 20130904 0000885590-13-000080.hdr.sgml : 20130904 20130904170927 ACCESSION NUMBER: 0000885590-13-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130903 FILED AS OF DATE: 20130904 DATE AS OF CHANGE: 20130904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Provencio Norma Ann CENTRAL INDEX KEY: 0001343811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 131078528 MAIL ADDRESS: STREET 1: 1041 WEST BADILLO STEET, SUITE 112 CITY: COVINA, CA STATE: CA ZIP: 91722 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-09-03 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001343811 Provencio Norma Ann 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 1 0 0 0 Common Stock, no par value 2013-09-03 4 S 0 5000 99.68 D 167282 D Sale made pursuant to an existing 10b5-1 plan. This number represents the weighted average sale price for all sales of common stock sold by the reporting officer. Actual sale executions were in the range of $99.44 and $99.92. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. This number represents common shares purchased and other equity awards that were previously reported in Table 1. by: Nicholas Zanoni for Norma Provencio 2013-09-04